Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides to treat Dystrophic Epidermolysis Bullosa

Antisense oligonucleotides to treat Dystrophic Epidermolysis Bullosa

US Patent 10370660 · Granted Aug 6, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted RNA editing2023
Oligonucleotides matching COL7A1 exon 73 for epidermolysis bullosa therapy2022
Oligonucleotides matching COL7A1 exon 73 for epidermolysis bullosa therapy2022
Antisense oligonucleotides to treat dystrophic epidermolysis bullosa2021
Antisense oligonucleotides to treat dystrophic epidermolysis bullosa2021
Antisense oligonucleotides to treat dystrophic epidermolysis bullosa2021
Use of single-stranded antisense oligonucleotide in prevention or treatment of g2020
Targeted RNA editing2020
Oligonucleotides matching COL7A1 exon 73 for epidermolysis bullosa therapy2020
Oligonucleotides matching COL7A1 exon 73 for epidermolysis bullosa therapy2020
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrop2018
Methods and means for treating DNA repeat instability associated genetic disorde2012